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Accuracy of mean arterial pressure and blood pressure
measurements in predicting pre-eclampsia: systematic review
and meta-analysis
Abstract
OBJECTIVE: To determine the accuracy of using systolic and diastolic blood pressure, mean arterial
pressure, and increase of blood pressure to predict pre-eclampsia. DESIGN: Systematic review with
meta-analysis of data on test accuracy. DATA SOURCES: Medline, Embase, Cochrane Library,
Medion, checking reference lists of included articles and reviews, contact with authors. Review methods
Without language restrictions, two reviewers independently selected the articles in which the accuracy
of blood pressure measurement during pregnancy was evaluated to predict pre-eclampsia. Data were
extracted on study characteristics, quality, and results to construct 2x2 tables. Summary receiver
operating characteristic curves and likelihood ratios were generated for the various levels and their
thresholds. RESULTS: 34 studies, testing 60 599 women (3341 cases of pre-eclampsia), were included.
In women at low risk for pre-eclampsia, the areas under the summary receiver operating characteristic
curves for blood pressure measurement in the second trimester were 0.68 (95% confidence interval 0.64
to 0.72) for systolic blood pressure, 0.66 (0.59 to 0.72) for diastolic blood pressure, and 0.76 (0.70 to
0.82) for mean arterial pressure. Findings for the first trimester showed a similar pattern. Second
trimester mean arterial pressure of 90 mm Hg or more showed a positive likelihood ratio of 3.5 (95%
confidence interval 2.0 to 5.0) and a negative likelihood ratio of 0.46 (0.16 to 0.75). In women deemed
to be at high risk, a diastolic blood pressure of 75 mm Hg or more at 13 to 20 weeks' gestation best
predicted pre-eclampsia: positive likelihood ratio 2.8 (1.8 to 3.6), negative likelihood ratio 0.39 (0.18 to
0.71). Additional subgroup analyses did not show improved predictive accuracy. CONCLUSION: When
blood pressure is measured in the first or second trimester of pregnancy, the mean arterial pressure is a
better predictor for pre-eclampsia than systolic blood pressure, diastolic blood pressure, or an increase of
blood pressure.
doi:10.1136/bmj.39540.522049.BE 
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Accuracy of mean arterial pressure and blood pressure
measurements in predicting pre-eclampsia: systematic
review and meta-analysis
Jeltsje S Cnossen, research fellow,1 Karlijn C Vollebregt, research fellow,3 Nynke de Vrieze, medical
student,1 Gerben ter Riet, associate professor,2 Ben W J Mol, professor,3 Arie Franx, consultant,4
Khalid S Khan, professor,5 Joris A M van der Post, professor3
ABSTRACT
Objective To determine the accuracy of using systolic and
diastolic blood pressure, mean arterial pressure, and
increase of blood pressure to predict pre-eclampsia.
Design Systematic review with meta-analysis of data on
test accuracy.
Data sourcesMedline, Embase, Cochrane Library,
Medion, checking reference lists of included articles and
reviews, contact with authors.
Review methodsWithout language restrictions, two
reviewers independently selected the articles inwhich the
accuracy of blood pressure measurement during
pregnancy was evaluated to predict pre-eclampsia. Data
were extracted on study characteristics, quality, and
results to construct 2×2 tables. Summary receiver
operating characteristic curves and likelihood ratios were
generated for the various levels and their thresholds.
Results 34 studies, testing 60 599 women (3341 cases
of pre-eclampsia), were included. In women at low risk
for pre-eclampsia, the areas under the summary receiver
operating characteristic curves for blood pressure
measurement in the second trimester were 0.68 (95%
confidence interval 0.64 to 0.72) for systolic blood
pressure, 0.66 (0.59 to 0.72) for diastolic blood
pressure, and 0.76 (0.70 to 0.82) for mean arterial
pressure. Findings for the first trimester showed a
similar pattern. Second trimester mean arterial pressure
of 90 mm Hg or more showed a positive likelihood ratio
of 3.5 (95% confidence interval 2.0 to 5.0) and a
negative likelihood ratio of 0.46 (0.16 to 0.75). In
women deemed to be at high risk, a diastolic blood
pressure of 75 mm Hg or more at 13 to 20 weeks’
gestation best predicted pre-eclampsia: positive
likelihood ratio 2.8 (1.8 to 3.6), negative likelihood ratio
0.39 (0.18 to 0.71). Additional subgroup analyses did
not show improved predictive accuracy.
ConclusionWhen blood pressure is measured in the first
or second trimester of pregnancy, the mean arterial
pressure is a better predictor for pre-eclampsia than
systolic blood pressure, diastolic blood pressure, or an
increase of blood pressure.
INTRODUCTION
Pre-eclampsia is an important disorder of pregnancy,
with potentially severe consequences for mother and
child.1 2The frequencyofpre-eclampsia variesbetween
2% and 7% in healthy nulliparous women.3-5 In pre-
eclampsia the interaction between the placenta and
maternal constitution is influenced by genetic and
environmental factors, causing a hypertensive inflam-
matory response.6 The gestosis is associated with low
birthweight and pretermdelivery but can also develop
at term, during labour, or even post partum.2 It has
been shown that women destined to develop pre-
eclampsia have higher mean arterial pressures in the
first and second trimester and even before pregnancy
than women with normal pregnancies.7 8
Blood pressure measurement is a screening test
routinely used in antenatal care to detect or predict
hypertensive disease.2 Accurate prediction of women
at risk for pre-eclampsia is crucial to judicious
allocation of monitoring resources and use of pre-
ventive treatment,9 with the prospect of improving
maternal and neonatal outcome. Studies investigating
the predictive accuracy of blood pressure measure-
ment report conflicting results. In view of these
conflicting reports it is uncertain whether blood
pressure measurement should be used routinely as a
predictive test or used only to diagnose hypertensive
disorders in pregnancy once they are suspected. We
carried out a systematic review to investigate the
accuracy of blood pressure measurement for predic-
tion of pre-eclampsia in pregnant women.
METHODS
This review was based on our previously published
protocol.10 Librarians carried out two electronic
searches of Medline, Embase, the Cochrane Library
(2006;4), and Medion (www.mediondatabase.nl/)
from inception to February 2007. The search strategy
(see bmj.com) consisted of MeSH or key terms related
to the disease (pre-eclampsia) and population (preg-
nant women) combinedwithmethodological filters for
identification of studies on diagnostic tests and causal
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factors.11-13 A second search strategy was done to
ascertain retrieval of relevant papers because “blood
pressure” is a term related to both our index test of
blood pressure measurement and the outcome pre-
eclampsia. We checked reference lists of relevant
studies to identify cited articles not captured by
electronic searches and contacted authors of primary
studies who had email addresses available. No
language restrictions were applied. We included
studies that reported on any technique to measure
blood pressure in pregnant women in any healthcare
setting and of any level of risk for pre-eclampsia. We
included test accuracy studies allowing generation of
2×2 tables.
Trained reviewers independently screened titles and
abstracts for relevance (JSC and KCV) and full papers
for inclusion and data extraction (JSC and NdV). An
explanation of extracted clinical, methodological, and
statistical data has been published.10 Studies were
assessed by one reviewer (JSC) for methodological
quality against the quality assessment of diagnostic
accuracy studies (QUADAS) criteria14 and randomly
checkedby a second reviewer (NdV).Howweassessed
items is summarised on bmj.com. We also assessed
application of preventive treatment. For multiple
publications of one dataset we included only the most
recent or complete study. Disagreements were
resolved by consensus or a third reviewer.
Reference standards for pre-eclampsia were a
persistent systolic blood pressure of 140 mm Hg or
more or a persistent diastolic blood pressure of 90 mm
Hg or more, or both, with proteinuria of 0.3 g/day or
more or a dipstick result of + or more (30 mg/dl in a
single urine sample), or both, new after 20 weeks of
gestation. Severe pre-eclampsia was defined as systolic
blood pressure of 160 mm Hg or more or diastolic
blood pressure of 110 mm Hg or more, or both, with
proteinuria 2.0 g/day ormore or a dipstick result of ++
+ or more, or both, of early onset (<34 weeks)
gestation. Superimposed pre-eclampsia was defined
as the development of proteinuria of 0.3 g/day ormore
or a dipstick result of + or more after 20 weeks of
gestation in chronically hypertensive women. Chronic
hypertension was defined as hypertension present
before pregnancy or detected before 20 weeks’
gestation and not resolving within three months after
delivery.15
Data synthesis
From the 2×2 tables we calculated sensitivity and
specificity and plotted their results in receiver operat-
ing characteristic plots. We pooled results among
groups of studies measuring similar blood pressure
variables (systolic, diastolic, mean arterial, or increase)
and similar outcome. We used a bivariate regression
model that takes into account the negative correlation
between sensitivity and specificity. This method has
been extensively described elsewhere and is recently
recommended for meta-analysis of diagnostic tests.16 17
Briefly, rather than using a single outcomemeasure for
each study, such as the diagnostic odds ratio, the
bivariate model preserves the two dimensional nature
of diagnostic data in a single model. This model
incorporates the correlation that may exist between
sensitivity and specificity within studies owing to
possible differences in threshold between studies.
When necessary the bivariate model uses a random
effects approach for both sensitivity and specificity,
allowing for heterogeneity beyond chance due to
clinical ormethodological differences between studies.
In addition the model acknowledges the difference in
precisionbywhich sensitivity and specificityhavebeen
measured in each study. This means that studies with a
larger number of women with pre-eclampsia receive
moreweight in the calculation of thepooled estimate of
sensitivity, whereas studies with more women without
pre-eclampsia are more influential in the pooling of
specificity. To estimate a summary receiver operating
characteristic curve and an area under that curve, we
used the results of themodelwith the smallest Akaike’s
information criterion (a measure of the goodness of fit
of an estimated statistical model).18 This model best
accounts for heterogeneity between studies. We
calculated areas under the curves in the first trimester
for the complete summary receiver operating char-
acteristic curve, which meant extension beyond the
available data. We also calculated pooled sensitivities
and specificities andderived likelihood ratios thereof.19
We carried out the following subgroup analyses,
defined a priori: outcome (severe pre-eclampsia),
sample (low risk sample v high risk sample), number
of readings (multiple measurement v single measure-
ment), and gestational age at testing (first trimester v
second trimester). Sensitivity analyses were done for
application of preventive treatment and study quality.
We considered studies of high quality when they
scored positive on at least four of the following items:
prospective design with consecutive recruitment,
Primary articles retrieved for detailed evaluation (n=186):
  From electronic searches (n=182) 
  From reference lists (n=4)
Potentially relevant citations identified from electronic
searches to capture primary articles on all tests
used in prediction of pre-eclampsia (n=19 548)
Potentially relevant citations on
blood pressure measurement (n=4000)
Primary articles included in systematic review (n=34)
References excluded after
screening titles or abstracts (n=3818)
Articles excluded (n=152):
  Not prediction (n=32)
  Reviews, letters, comments, or editorials (n=16)
  Pre-eclamptic toxaemia not separate outcome or
    pregnancy induced hypertension only (n=49)
  No test accuracy (n=19)
  Insufficient data to construct 2x2 table (n=31) 
  Data duplication (n=1)
  Other (n=4)
Fig 1 | Literature identification and study selection
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appropriate reference standard, follow-up greater than
90%, adequate description of the index test, and
reporting of preventive treatment.
All statistical analyses were done using SAS 9.1 for
Windows (Proc NLMixed in the bivariate model). We
used STATA/SE 9.0 0 to draw the receiver operating
characteristic plots.
RESULTS
Figure 1 summarises the flow of studies through the
review. Overall, 34 studiesw1-w34 screening 60 599
women (3341 pre-eclamptic women) were included,
which comprised 28 cohorts, three randomised con-
trolled trials, and three case-control studies resulting in
135 2×2 tables. None of 12 authors contacted about
unclear information in their articles provided addi-
tional information. The main reason given was “data
not available.” Twenty eight studies were prospective
and six retrospective. The risk profile of the women
included in the studies are on bmj.com. Sample sizes
ranged from 22 to 22 582 women. The incidence rates
for pre-eclampsia ranged from 0.8% to 40.8% (median
incidence 6.3%; case-control studies excluded). Seven
studies reported on “high risk” women (range for
incidence rates 2.0% to 28.7%). Since the criteria for
high risk varied fromwomenwith an abnormal uterine
artery detected byDoppler ultrasonography towomen
with chronic hypertension or diabetes, this may have
caused the great variation in incidence. Fourteen
studies explicitly reported exclusion of women with
chronic hypertension and four studies reported inclu-
sion of women with chronic hypertension (women at
high risk). Twenty eight studies reported on blood
pressure measurement in the second trimester. Eigh-
teen studies reported on mean arterial pressure,
defined as (diastolic blood pressure+one third×(systo-
lic blood pressure−diastolic blood pressure) or auto-
mated mean arterial pressure readings. Six studies
reported on systolic blood pressure; 11 on diastolic
blood pressure; and three on increase of systolic blood
pressure or increase of diastolic blood pressure, or
both. One studyw33 reported on diastolic midline
estimating statistic of rhythm (MESOR) and two
studiesw28 w31 reported on absolute blood pressure
levels. Since both randomised controlled trials in
women at low risk investigated calcium supplementa-
tion, which has not been proved effective, 20 and one
only included a placebo group, we analysed the trials
together with the cohort studies. Four studies were
excluded from the final meta-analysis (three case-
control studiesw2 w15 w20 to further enhance validity and
one study without a threshold for the index testw26).
Quality assessment
Figure 2 summarises the results of quality assessment.
More than 70% of studies met the following items for
quality assessment: period between tests, avoidance of
partial and differential verification, independent refer-
ence test, blind assessment of index test, and clinical
data available. Less than 30%of studies scored positive
on the items for adequate patient spectrum; adequate
descriptions of selection criteria, index test, and
reference test; and blind assessment of reference test.
Seven publications reported on the application of
preventive treatment.
Data analysis
Figure 3 shows the receiver operating characteristic
plots for the results for systolic bloodpressure, diastolic
bloodpressure,meanarterial pressure, and increasesof
systolic blood pressure or diastolic blood pressure
according to riskand trimester. Somestudies are shown
several times with several thresholds. Figure 4 shows
the summary receiver operating characteristic curves
for systolic blood pressure, diastolic blood pressure,
and mean arterial pressure in low risk populations in
the second trimester.Theareaunder the curvewas0.68
(95%confidence interval0.64 to0.72) for systolicblood
pressure, 0.66 (0.59 to 0.72) for diastolic blood
pressure, and 0.76 (0.70 to 0.82) for mean arterial
pressure. For a specificity of 90% the sensitivities of
diastolic blood pressure and mean arterial pressure
were both 35%, whereas for systolic blood pressure the
sensitivity was only 24%. For the six studies with a
mean arterial pressure threshold of 85mmHg ormore
the pooled sensitivity was 52% (95% confidence
interval 28% to 75%) and pooled specificity 84%
(95%confidence interval 75% to94%); derivedpositive
likelihood ratio 3.3 (95% confidence interval 2.2 to 4.3)
and negative likelihood ratio 0.57 (95% confidence
interval 0.35 to 0.80). A mean arterial pressure of
90mmHg ormore showed a pooled sensitivity of 62%
(35% to 89%) and a pooled specificity of 82% (72% to
92%); derived positive likelihood ratio 3.5 (2.0 to 5.0)
and negative likelihood ratio 0.46 (0.16 to 0.75). The
three studies on increase of systolic blood pressure or
increase of diastolic blood pressure, or both, showed
poor predictive accuracy (fig 3). Poor predictive
accuracy was shown for an increase in systolic blood
pressure or diastolic blood pressure compared with
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Fig 2 | Summary of quality assessment
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baselinew16 w27 and an increase of blood pressure
compared with later gestational ages.w32
Subgroup and sensitivity analysis
Severe pre-eclampsia was reported by only one cohort
studyw25 (first trimester: positive likelihood ratio 2.9,
1.9 to 4.2; negative likelihood ratio 0.74, 0.59 to 0.88)
and one case-control studyw2 (positive likelihood ratio
4.3, 2.2 to 8.9; negative likelihood ratio 0.54, 0.45 to
0.70).
In high risk populations a diastolic blood pressure of
75 mm Hg or more at 13 to 20 weeks’ gestation best
predicted pre-eclampsia (positive likelihood ratio 2.8,
1.8 to 3.6; negative likelihood ratio 0.39, 0.18 to
0.71).w26 Another study showed a positive likelihood
ratioof2.8andnegative likelihoodratioof0.00, but this
study had only one case of pre-eclampsia (sensitivity
100%).
In 24 studies it was unclear whether single (in
doctor’s surgery) or multiple (ambulatory blood
pressure monitoring during the daytime) readings
were reported.When it was assumed that these studies
carried out single measurements, the areas under the
curves for testing low risk populations in the second
trimester remained 0.68 for systolic blood pressure,
0.66 for diastolic blood pressure, and 0.76 for mean
arterial pressure. Areas under the curves for blood
pressure measurement in the first trimester were 0.66
for systolic blood pressure, 0.67 for diastolic blood
pressure, and 0.79 for mean arterial pressure.
Studies that excludedwomenwith chronichyperten-
sion showedpositive likelihood ratios for systolicblood
pressure of 1.9 (95% confidence interval 0.0 to 3.7),
diastolic blood pressure 2.7 (0.0 to 5.5), and mean
arterial pressure 2.6 (1.5 to 3.7). Negative likelihood
ratioswere, respectively, 0.6 (0.4 to 0.6), 0.6 (0.4 to 0.7),
and 0.5 (0.3 to 0.8).
Sensitivity analysis on preventive treatment was
considered impractical because 25 studies (80%) did
not report on it. None of the studies met the criteria for
high quality.
DISCUSSION
We reviewed the literature on the accuracy of blood
pressure measurement during pregnancy to predict
pre-eclampsia. Mean arterial pressure predicted pre-
eclampsia fairly well (area under the curve between
0.70 and 0.80) whereas systolic blood pressure;
diastolic blood pressure; and an increase of systolic
blood pressure or increase of diastolic blood pressure,
or both, predicted pre-eclampsia poorly (area under
the curve <0.70). In low risk populations a mean
arterial pressure in the second trimester best predicted
pre-eclampsia, with an area under the curve of 0.76.An
increasedmean arterial pressure of 90mmHg ormore
in the second trimester, however, showed a small
increase in the likelihood of developing pre-eclampsia
(positive likelihood ratio 3.5; negative likelihood ratio
0.46). In high risk populations a diastolic blood
pressure of 75 mm Hg or more at 13 to 20 weeks’
gestation best predicted pre-eclampsia, although the
accuracy of prediction wasmodest (positive likelihood
ratio 2.8; negative likelihood ratio 0.39). Subgroup
analyses were limited and did not improve predictive
accuracy.
Strengths and weaknesses of the review
We carried out extensive literature searches without
language restrictions, assessed the quality of the studies
and the reporting, and used contemporary statistical
methods. Many studies did not distinguish between
pre-eclampsia and other hypertensive disorders in
pregnancy (fig 1), nor did many report sufficient
information to construct a 2×2 table. Contacting
authors did not increase the number of included
studies, resulting in a potential loss of relevant data.
Quality assessment and subgroup analyses were
hindered by unclear reporting in many studies, which
is a common problem in diagnostic reviews. Previous
studies reported that poor study design and conduct
can affect estimates of diagnostic accuracy,21 22 but it is
not entirely clear how individual aspects of qualitymay
affect this and towhatmagnitude in this particular area.
Many strategies to account for differences in quality
have been applied but none led to estimates that were
systematically less optimistic than ignoring quality in
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Fig 3 | Receiver operating characteristic plots for all results according to timing of test during
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meta-analyses of test accuracy studies. 23 24As a result of
unclear reporting it was not possible to carry out
multivariate subgroup analysis on the basis of indivi-
dual quality criteria, therefore we reported the overall
results. Poor reporting occurred in details of the index
test and reference standard, patient selection criteria,
and blinding. Definitions of pre-eclampsia have
changed over time, with previous definitions including
oedema and increases in blood pressure. Themeasure-
ment of blood pressure was poorly reported, under-
estimating the importance of recording diastolic blood
pressurewithKorotkoff phaseVas this ismore reliably
recorded andmore closely reflects directmeasurement
of diastolic blood pressure.25-27 Poor reporting of the
device used underestimates the importance of its
validation for blood pressure measurement during
pregnancy. 28 29 Poor reporting of patient selection
criteria may partly explain the great variability of
incidence rates of pre-eclampsia not only between but
within the categories of populations considered high
risk or low risk. In some of the studies the population
that was intended to be recruited differed from the
population enrolled. The selection criteria for high risk
varied from abnormal uterine artery detected by
Doppler ultrasonography to pre-existent disease or
mixtures thereof, such as chronic hypertension or
diabetes. Large cohort studies (>300 000 women)
reflecting unselected populations, however, showed
incidence rates of pre-eclampsia between 0.8% and
5.1%.30-32 This suggests that small studies of low risk or
unselected populations within this review may have
been prone to selection bias. Studies that tested inmid-
trimester should have taken into account that the
predictive accuracy at 14 weeksmay differ from that at
27 weeks because by definition no one develops pre-
eclampsia in the first half of pregnancy.
Strengths and weaknesses in relation to other studies
A published review in this area was restricted to
evaluating risk factors for pre-eclampsia at the first
antenatal visit.33 This review included four studies on
blood pressure and concluded that the risk of pre-
eclampsia was increased in women with a raised
diastolic blood pressure (>80 mm Hg) at the first
antenatal visit (relative risk 1.48, 95% confidence
interval 1.0 to 1.9). Other published reviews did not
apply appropriate methods for systematic reviews of
screening tests or did not distinguish between different
hypertensive disorders.34-39 Some of these reviews
concluded that an increased mean arterial pressure
(≥85 mm Hg or ≥90 mm Hg) predicted transient
hypertension rather than pre-eclampsia 34-36 and that
pregnant women with diastolic blood pressures of
70mmHgormoreormeanarterial pressuresof 80mm
Hg ormore in the second trimester have a small risk of
developing pre-eclampsia.38
Unanswered questions, future research, and implications
When deciding on whether a predictive test should be
applied in clinical practice several things need to be
considered: the prevalence of the disease and the
predictive accuracyof the test, the cost of the test and its
acceptability to patients, and the treatments available
for the disease in question. Pre-eclampsia is a disease
with relatively low prevalence. A clinically useful test
would need to have a great area under the curve
(preferably >0.80) or high positive likelihood ratio
(>10) and lownegative likelihood ratio (<0.10).40 From
the results of this review mean arterial pressure still
shows the greatest predictive accuracy in the first and
second trimesters, with a relatively small likelihood
ratio (positive likelihood ratio 3.5; negative likelihood
ratio 0.46). In clinical practice measurement of mean
arterial pressure at the first antenatal visitmay improve
the accuracy for estimating risk of pre-eclampsia.
Although it will probably not make a clinical impact
in isolation, it is highly likely that the prediction of pre-
eclampsia will evolve through the development of
algorithms that possibly include clinical, biophysical,
and biochemical markers. Recently the authors of a
large prospective study concluded that maternal
variables, together with mean arterial pressure at 11
+0 to 13+6 weeks, identify a group at high risk for pre-
eclampsia.41 Our data cannot rationalise current
obstetrical practice of repeated blood pressure mea-
surements during the first and second trimester in
healthywomenwithanormalbloodpressureat the first
antenatal visit. A formal cost utility analysis is needed.
Women can experience unnecessary anxiety when
being identified at risk of pre-eclampsia after an
antenatal test. At present no pharmacological treat-
ment or management strategy (for example, regular
ultrasound scanning, early delivery) has been shown to
effectively prevent the development of pre-eclampsia.
Early antihypertensive treatment has been shown to
only prevent severe hypertension, not any other
complication. Research into aspirin as a treatment
has, however, shown a modest preventive effect
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(relative risks of 0.9 for pre-eclampsia and 0.9 for fetal
growth restriction42) in the absence of any serious side
effects. Aspirin is a cheap and readily available
preventive treatment. In this instance a false negative
test result is potentially more harmful than a false
positive test result.
It is imperative to differentiate between mild and
severe disease because early or severe pre-eclampsia is
associated with raised rates of maternal morbidity and
mortality and has pronounced risks for the fetus, such
as severe fetal growth restriction.2-43 Future research
should also concentrate on the development of
algorithms that combine biochemical and biophysical
markers, including blood pressure measurement—a
diagnosticprocessused in clinical care.Thesemayhelp
improve thepredictive accuracyof the tests to clinically
important values.
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